TY - JOUR AU - de Oliveira Andrade, Luis Jesuino AU - Santos França, Larissa AU - Santos França, Luciana AU - Vinhaes Bittencourt, Alcina Maria AU - Santos França, Caroline PY - 2014/07/21 Y2 - 2024/03/29 TI - Off-label treatment in diabetic retinopathy JF - Revista de Ciências Médicas e Biológicas JA - cmbio VL - 13 IS - 1 SE - Artigos de revisão DO - 10.9771/cmbio.v13i1.9024 UR - https://periodicos.ufba.br/index.php/cmbio/article/view/9024 SP - 78-84 AB - <p class="MsoNormal" style="margin-bottom: 0.0001pt; text-align: justify;"><strong><em><span style="font-size: 8.0pt; font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-BoldItalic; mso-ansi-language: EN-US;" lang="EN-US">Introduction: </span></em></strong><em><span style="font-size: 8.0pt; font-family: Calibri-Italic; mso-hansi-font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-Italic; mso-ansi-language: EN-US;" lang="EN-US">The prescribing a drug without the indications for which the drug was originally approved by regulators is internationally known as prescribing “off-label”. </span></em><strong><em><span style="font-size: 8.0pt; font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-BoldItalic; mso-ansi-language: EN-US;" lang="EN-US">Objective</span></em></strong><em><span style="font-size: 8.0pt; font-family: Calibri-Italic; mso-hansi-font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-Italic; mso-ansi-language: EN-US;" lang="EN-US">: To describe the off-label therapy in diabetic retinopathy, reported international scientific literature, through an integrative bibliographical review. </span></em><strong><em><span style="font-size: 8.0pt; font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-BoldItalic; mso-ansi-language: EN-US;" lang="EN-US">Method</span></em></strong><em><span style="font-size: 8.0pt; font-family: Calibri-Italic; mso-hansi-font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-Italic; mso-ansi-language: EN-US;" lang="EN-US">: Integrative review by searching the Medline international database for review of manuscripts. </span></em><strong><em><span style="font-size: 8.0pt; font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-BoldItalic; mso-ansi-language: EN-US;" lang="EN-US">Results</span></em></strong><em><span style="font-size: 8.0pt; font-family: Calibri-Italic; mso-hansi-font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-Italic; mso-ansi-language: EN-US;" lang="EN-US">: A total 852 scientific productions were identified, and 37 studies were selected by contain information about the off-label therapy in diabetic retinopathy. </span></em><strong><em><span style="font-size: 8.0pt; font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-BoldItalic; mso-ansi-language: EN-US;" lang="EN-US">Conclusion</span></em></strong><em><span style="font-size: 8.0pt; font-family: Calibri-Italic; mso-hansi-font-family: Calibri-BoldItalic; mso-bidi-font-family: Calibri-Italic; mso-ansi-language: EN-US;" lang="EN-US">: The practice of off-label prescribing in diabetic retinopathy has benefits, and in some situations is the only treatment available.</span></em></p> ER -